Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-26-130719

SVP, Chief Development Officer sold 6,933 shares at $19.18 ($132,961)

From the SEC's structured data for this filing

Trades in this filing

CICIC DRAGAN · SVP, Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-18 Sale : show line 1 in the form −6,933 $19.18 $132,961 557,361 D
Open-market sales · 6,933 sh · avg $19.18 · $132,961
Loading xslF345X06/tm2630378-2_4seq1.xml…